{"id":2068,"date":"2025-06-09T19:19:21","date_gmt":"2025-06-09T19:19:21","guid":{"rendered":"https:\/\/blogs.bmj.com\/jmg\/?p=2068"},"modified":"2026-02-22T01:09:05","modified_gmt":"2026-02-22T01:09:05","slug":"de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jmg\/2025\/06\/09\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\/","title":{"rendered":"De novo heterozygous missense variants in ATP11A are associated with refractory focal epilepsy (Contributed by Dr. Zi-Long Ye)"},"content":{"rendered":"<p>The majority of focal epilepsy with unknown causes has genetic predisposition. This study demonstrates that <em>de novo <\/em>missense variants in <em>ATP11A<\/em> are associated with refractory focal epilepsy. Further systematic analysis indicates that variants located in transmembrane regions (TMs) are related to severe and multiple neurological symptoms, whereas non-TM variants are associated with mild and single symptoms. Additionally, all patients have a gradually worsening potential. These findings provide useful insights for early diagnosis and prognosis of the patients with <em>ATP11A<\/em> variants. (<a href=\"https:\/\/jmg.bmj.com\/content\/62\/6\/396\">https:\/\/jmg.bmj.com\/content\/62\/6\/396<\/a> )<\/p>\n<p><a href=\"https:\/\/blogs.bmj.com\/jmg\/2025\/06\/09\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\/fig1-2\/\" rel=\"attachment wp-att-2069\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2069\" src=\"https:\/\/blogs.bmj.com\/jmg\/files\/2025\/06\/Fig1-224x300.jpg\" alt=\"\" width=\"224\" height=\"300\" srcset=\"https:\/\/blogs.bmj.com\/jmg\/files\/2025\/06\/Fig1-224x300.jpg 224w, https:\/\/blogs.bmj.com\/jmg\/files\/2025\/06\/Fig1-765x1024.jpg 765w, https:\/\/blogs.bmj.com\/jmg\/files\/2025\/06\/Fig1-768x1028.jpg 768w, https:\/\/blogs.bmj.com\/jmg\/files\/2025\/06\/Fig1-1148x1536.jpg 1148w, https:\/\/blogs.bmj.com\/jmg\/files\/2025\/06\/Fig1-1530x2048.jpg 1530w, https:\/\/blogs.bmj.com\/jmg\/files\/2025\/06\/Fig1-640x857.jpg 640w, https:\/\/blogs.bmj.com\/jmg\/files\/2025\/06\/Fig1-scaled.jpg 1913w\" sizes=\"auto, (max-width: 224px) 100vw, 224px\" \/><\/a><!--TrendMD v2.4.8--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The majority of focal epilepsy with unknown causes has genetic predisposition. This study demonstrates that de novo missense variants in ATP11A are associated with refractory focal epilepsy. Further systematic analysis indicates that variants located in transmembrane regions (TMs) are related to severe and multiple neurological symptoms, whereas non-TM variants are associated with mild and single [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/jmg\/2025\/06\/09\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2068","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>De novo heterozygous missense variants in ATP11A are associated with refractory focal epilepsy (Contributed by Dr. Zi-Long Ye) - JMG Contact blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/jmg\/2025\/06\/09\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"De novo heterozygous missense variants in ATP11A are associated with refractory focal epilepsy (Contributed by Dr. Zi-Long Ye) - JMG Contact blog\" \/>\n<meta property=\"og:description\" content=\"The majority of focal epilepsy with unknown causes has genetic predisposition. This study demonstrates that de novo missense variants in ATP11A are associated with refractory focal epilepsy. Further systematic analysis indicates that variants located in transmembrane regions (TMs) are related to severe and multiple neurological symptoms, whereas non-TM variants are associated with mild and single [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/jmg\/2025\/06\/09\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\/\" \/>\n<meta property=\"og:site_name\" content=\"JMG Contact blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-09T19:19:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-22T01:09:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blogs.bmj.com\/jmg\/files\/2025\/06\/Fig1-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1913\" \/>\n\t<meta property=\"og:image:height\" content=\"2560\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"hqqu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HuiQiQu\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hqqu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/06\\\/09\\\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/06\\\/09\\\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\\\/\"},\"author\":{\"name\":\"hqqu\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\"},\"headline\":\"De novo heterozygous missense variants in ATP11A are associated with refractory focal epilepsy (Contributed by Dr. Zi-Long Ye)\",\"datePublished\":\"2025-06-09T19:19:21+00:00\",\"dateModified\":\"2026-02-22T01:09:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/06\\\/09\\\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\\\/\"},\"wordCount\":106,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/06\\\/09\\\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2025\\\/06\\\/Fig1-224x300.jpg\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/06\\\/09\\\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/06\\\/09\\\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/06\\\/09\\\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\\\/\",\"name\":\"De novo heterozygous missense variants in ATP11A are associated with refractory focal epilepsy (Contributed by Dr. Zi-Long Ye) - JMG Contact blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/06\\\/09\\\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/06\\\/09\\\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2025\\\/06\\\/Fig1-224x300.jpg\",\"datePublished\":\"2025-06-09T19:19:21+00:00\",\"dateModified\":\"2026-02-22T01:09:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/06\\\/09\\\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/06\\\/09\\\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/06\\\/09\\\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2025\\\/06\\\/Fig1-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2025\\\/06\\\/Fig1-scaled.jpg\",\"width\":1913,\"height\":2560},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/06\\\/09\\\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"De novo heterozygous missense variants in ATP11A are associated with refractory focal epilepsy (Contributed by Dr. Zi-Long Ye)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"name\":\"JMG Contact blog\",\"description\":\"JMG Contact blog\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\",\"name\":\"JMG Contact blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"width\":300,\"height\":34,\"caption\":\"JMG Contact blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\",\"name\":\"hqqu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"caption\":\"hqqu\"},\"description\":\"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.\",\"sameAs\":[\"https:\\\/\\\/x.com\\\/HuiQiQu\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/author\\\/hqiqu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"De novo heterozygous missense variants in ATP11A are associated with refractory focal epilepsy (Contributed by Dr. Zi-Long Ye) - JMG Contact blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/jmg\/2025\/06\/09\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\/","og_locale":"en_US","og_type":"article","og_title":"De novo heterozygous missense variants in ATP11A are associated with refractory focal epilepsy (Contributed by Dr. Zi-Long Ye) - JMG Contact blog","og_description":"The majority of focal epilepsy with unknown causes has genetic predisposition. This study demonstrates that de novo missense variants in ATP11A are associated with refractory focal epilepsy. Further systematic analysis indicates that variants located in transmembrane regions (TMs) are related to severe and multiple neurological symptoms, whereas non-TM variants are associated with mild and single [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/jmg\/2025\/06\/09\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\/","og_site_name":"JMG Contact blog","article_published_time":"2025-06-09T19:19:21+00:00","article_modified_time":"2026-02-22T01:09:05+00:00","og_image":[{"width":1913,"height":2560,"url":"https:\/\/blogs.bmj.com\/jmg\/files\/2025\/06\/Fig1-scaled.jpg","type":"image\/jpeg"}],"author":"hqqu","twitter_card":"summary_large_image","twitter_creator":"@HuiQiQu","twitter_misc":{"Written by":"hqqu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/jmg\/2025\/06\/09\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2025\/06\/09\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\/"},"author":{"name":"hqqu","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b"},"headline":"De novo heterozygous missense variants in ATP11A are associated with refractory focal epilepsy (Contributed by Dr. Zi-Long Ye)","datePublished":"2025-06-09T19:19:21+00:00","dateModified":"2026-02-22T01:09:05+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2025\/06\/09\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\/"},"wordCount":106,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2025\/06\/09\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2025\/06\/Fig1-224x300.jpg","inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/jmg\/2025\/06\/09\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/jmg\/2025\/06\/09\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\/","url":"https:\/\/blogs.bmj.com\/jmg\/2025\/06\/09\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\/","name":"De novo heterozygous missense variants in ATP11A are associated with refractory focal epilepsy (Contributed by Dr. Zi-Long Ye) - JMG Contact blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2025\/06\/09\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\/#primaryimage"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2025\/06\/09\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2025\/06\/Fig1-224x300.jpg","datePublished":"2025-06-09T19:19:21+00:00","dateModified":"2026-02-22T01:09:05+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2025\/06\/09\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/jmg\/2025\/06\/09\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/2025\/06\/09\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\/#primaryimage","url":"https:\/\/blogs.bmj.com\/jmg\/files\/2025\/06\/Fig1-scaled.jpg","contentUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2025\/06\/Fig1-scaled.jpg","width":1913,"height":2560},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/jmg\/2025\/06\/09\/de-novo-heterozygous-missense-variants-in-atp11a-are-associated-with-refractory-focal-epilepsy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/jmg\/"},{"@type":"ListItem","position":2,"name":"De novo heterozygous missense variants in ATP11A are associated with refractory focal epilepsy (Contributed by Dr. Zi-Long Ye)"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/jmg\/#website","url":"https:\/\/blogs.bmj.com\/jmg\/","name":"JMG Contact blog","description":"JMG Contact blog","publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/jmg\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/jmg\/#organization","name":"JMG Contact blog","url":"https:\/\/blogs.bmj.com\/jmg\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","contentUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","width":300,"height":34,"caption":"JMG Contact blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b","name":"hqqu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","caption":"hqqu"},"description":"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.","sameAs":["https:\/\/x.com\/HuiQiQu"],"url":"https:\/\/blogs.bmj.com\/jmg\/author\/hqiqu\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/2068","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/comments?post=2068"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/2068\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/media?parent=2068"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/categories?post=2068"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/tags?post=2068"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}